113 related articles for article (PubMed ID: 10635069)
1. [1977 mortality rate in HIV-infected patients presenting with hepatitis C cirrhosis. Results of the GERMIVC multicenter survey conducted in French departments of internal medicine or infectious disease].
Geffray L; Rosenthal E; Cacoub P; Perronne C; Veyssier P; Raguin G; Cevallos R; Patey O; Bouchard O; Loury I; Delarocque E; Goujard C; Estavoyer JM; Dupont C; Grappin M; Morand P; Laurichesse H; Vuitton D
Rev Med Interne; 1999 Dec; 20(12):1082-7. PubMed ID: 10635069
[TBL] [Abstract][Full Text] [Related]
2. Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997.
Cacoub P; Geffray L; Rosenthal E; Perronne C; Veyssier P; Raguin G;
Clin Infect Dis; 2001 Apr; 32(8):1207-14. PubMed ID: 11283811
[TBL] [Abstract][Full Text] [Related]
3. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001.
Giordano TP; Kramer JR; Souchek J; Richardson P; El-Serag HB
Arch Intern Med; 2004 Nov; 164(21):2349-54. PubMed ID: 15557414
[TBL] [Abstract][Full Text] [Related]
4. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
Bird SM; Goldberg DJ; Hutchinson SJ
J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
[TBL] [Abstract][Full Text] [Related]
5. Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalité 2005 study.
Salmon-Ceron D; Rosenthal E; Lewden C; Bouteloup V; May T; Burty C; Bonnet F; Costagliola D; Jougla E; Semaille C; Morlat P; Cacoub P; Chêne G;
J Hepatol; 2009 Apr; 50(4):736-45. PubMed ID: 19231018
[TBL] [Abstract][Full Text] [Related]
6. Effect of liver fibrosis on long-term mortality in HIV/hepatitis C virus-coinfected individuals who are evaluated to receive interferon therapies in the highly active antiretroviral therapy era.
Sanmartin R; de Felipe E; Tor J; Sanvicens A; Barluenga E; Martinez E; Muga R; Jou A; Ojanguren I; López JJ; Clotet B; Tural C
AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1235-43. PubMed ID: 22443303
[TBL] [Abstract][Full Text] [Related]
7. Risk of diabetes in HIV-infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort.
Provoost A; Dramé M; Cotte L; Cuzin L; Garraffo R; Rey D; Raffi F; Poizot-Martin I; Pugliese P; Bani-Sadr F;
Aliment Pharmacol Ther; 2018 Aug; 48(3):281-289. PubMed ID: 29901821
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C in France: a national survey in the Departments of Internal Medicine and Infectious Diseases. The GERMIVIC (Joint Study Group on Hepatitis C virus of the French National Society of Internal Medicine and the French Society of Infectious Diseases).
Raguin G; Rosenthal E; Cacoub P; Veyssier P; Piette JC; Micoud M
Eur J Epidemiol; 1998 Sep; 14(6):545-8. PubMed ID: 9794120
[TBL] [Abstract][Full Text] [Related]
9. Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study.
Gjærde LI; Shepherd L; Jablonowska E; Lazzarin A; Rougemont M; Darling K; Battegay M; Braun D; Martel-Laferriere V; Lundgren JD; Rockstroh JK; Gill J; Rauch A; Mocroft A; Klein MB; Peters L
Clin Infect Dis; 2016 Sep; 63(6):821-829. PubMed ID: 27307505
[TBL] [Abstract][Full Text] [Related]
10. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy.
Tedaldi EM; Baker RK; Moorman AC; Alzola CF; Furhrer J; McCabe RE; Wood KC; Holmberg SD;
Clin Infect Dis; 2003 Feb; 36(3):363-7. PubMed ID: 12539079
[TBL] [Abstract][Full Text] [Related]
11. Imaging Features and Prognosis of Hepatocellular Carcinoma in Patients with Cirrhosis Who Are Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus.
Lewin M; Gelu-Simeon M; Ostos M; Boufassa F; Sobesky R; Teicher E; Meyer L; Fontaine H; Salmon-Céron D; Samuel D; Seror O; Trinchet JC; Duclos-Vallée JC
Radiology; 2015 Nov; 277(2):443-53. PubMed ID: 25961631
[TBL] [Abstract][Full Text] [Related]
12. The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C.
Kramer JR; Giordano TP; Souchek J; Richardson P; Hwang LY; El-Serag HB
Am J Gastroenterol; 2005 Jan; 100(1):56-63. PubMed ID: 15654781
[TBL] [Abstract][Full Text] [Related]
13. Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study).
Rosenthal E; Pialoux G; Bernard N; Pradier C; Rey D; Bentata M; Michelet C; Pol S; Perronne C; Cacoub P;
J Viral Hepat; 2007 Mar; 14(3):183-8. PubMed ID: 17305884
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study.
Anderson KB; Guest JL; Rimland D
Clin Infect Dis; 2004 Nov; 39(10):1507-13. PubMed ID: 15546088
[TBL] [Abstract][Full Text] [Related]
15. Liver-related deaths in HIV-infected patients between 1995 and 2010 in France: the Mortavic 2010 study in collaboration with the Agence Nationale de Recherche sur le SIDA (ANRS) EN 20 Mortalité 2010 survey.
Rosenthal E; Roussillon C; Salmon-Céron D; Georget A; Hénard S; Huleux T; Gueit I; Mortier E; Costagliola D; Morlat P; Chêne G; Cacoub P;
HIV Med; 2015 Apr; 16(4):230-9. PubMed ID: 25522874
[TBL] [Abstract][Full Text] [Related]
16. Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol.
Salmon-Ceron D; Lewden C; Morlat P; Bévilacqua S; Jougla E; Bonnet F; Héripret L; Costagliola D; May T; Chêne G;
J Hepatol; 2005 Jun; 42(6):799-805. PubMed ID: 15973779
[TBL] [Abstract][Full Text] [Related]
17. Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study).
Rosenthal E; Poirée M; Pradier C; Perronne C; Salmon-Ceron D; Geffray L; Myers RP; Morlat P; Pialoux G; Pol S; Cacoub P;
AIDS; 2003 Aug; 17(12):1803-9. PubMed ID: 12891066
[TBL] [Abstract][Full Text] [Related]
18. Care of hepatitis C virus infection in France: modifications in three consecutive surveys between 1995 and 2010.
Geri G; Maynard M; Rosenthal E; Fontaine H; Lacombe K; Slama L; Goujard C; Loustaud-Ratti V; Bergmann JF; Morlat P; Vittecoq D; Alric L; Cacoub P;
Liver Int; 2014 Oct; 34(9):1349-57. PubMed ID: 25368876
[TBL] [Abstract][Full Text] [Related]
19. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.
Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA
World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450
[TBL] [Abstract][Full Text] [Related]
20. The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam.
Matser A; Urbanus A; Geskus R; Kretzschmar M; Xiridou M; Buster M; Coutinho R; Prins M
Addiction; 2012 Mar; 107(3):614-23. PubMed ID: 21919987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
